UW
Evonik Industries Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lipid Nanoparticles (LNP) Platform | mRNA Vaccines & Therapies, Gene Therapy | Commercial/Development |
| Rhamnolipid Biosurfactants | Sustainable Home Care & Personal Care Ingredients | Commercial Scale-up |
| TROGAMID® R Transparent Polyamide | Recycled Plastics for Consumer Goods | Commercial Launch |
| Protectosil ECO-TRETE® ANTIGRAFFITI | PFAS-free Anti-Graffiti Coating | Commercial Launch |
| Medical Device Biomaterials | Orthopedics, Cardiovascular, Drug-Eluting Devices | Development & Commercial |
| Cell Culture Media Ingredients | Biopharmaceutical Production | Commercial |
| Circular Economy Program (e.g., PU Foam Recycling) | Chemical Recycling of Post-Consumer Waste | Pilot/Development |
Leadership Team at Evonik Industries
CK
Christian Kullmann
Chairman of the Executive Board (CEO)
MS
Maike Schuh
Member of the Executive Board (HR)
TW
Thomas Wessel
Member of the Executive Board (Sustainability)
HS
Harald Schwager
Member of the Executive Board (Innovation/Segment)